Service Communautaire d'Information sur la Recherche et le Développement - CORDIS

Control of lung infection, allergy and inflammation: assessment of the therapeutic potential of recombinant forms of lung surfactant proteins sp-a and sp-d.

De 2000-09-01 à 2003-11-30

Détails concernant le projet

Coût total:

EUR 1 867 273

Contribution de l'UE:

EUR 1 299 957

Coordonné à/au(x)/en:

United Kingdom

Régime de financement:

CSC - Cost-sharing contracts

Objectif

Coordinateur

Medical Research Council (MRC)
United Kingdom
20 Park Crescent
W1N 4AL London
United Kingdom
See on map
Contact administratif: Anne-Marie CORIAT

Participants

ALTANA PHARMA A.G.
Germany
Byk-Gulden Str. 2
78467 KONSTANZ
Germany
See on map
Contact administratif: Heinz RADTKE
UNIVERSIDAD COMPLUTENSE DE MADRID
Spain
Ciudad Universitaria s/n
28040 MADRID
Spain
See on map
Contact administratif: Agustin ZAPATA-GONZALEZ
UNIVERSITY OF SOUTHERN DENMARK - UNIVERSITY OF ODENSE
Denmark
Winsloeevparken 21
5000 ODENSE
Denmark
Contact administratif: Vagn HOLMEGAARD
UTRECHT UNIVERSITY
Netherlands
Yalelaan 1
3584 CL UTRECHT
Netherlands
See on map
Contact administratif: G.A. CORNELISSEN